Reportedly, Johnson & Johnson (JNJ) announced the appointment of Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors. Currently, in his role as the Chairman and CEO of Honeywell, Darius Adamczyk has helped to bring solutions and technology to market that help to make the world safer, more sustainable, more productive, and built a culture of excellence.
Mr. Adamczyk is an MBA from Harvard University with a master’s degree in computer engineering from Syracuse University and a bachelor’s degree in electrical and computer engineering from Michigan State University.
“I am delighted to welcome Darius to Johnson & Johnson’s Board of Directors. Darius is an accomplished global leader with decades of experience and a track record of growing businesses. He is also a champion of sustainability and investments in innovation to improve the lives of people around the world. Darius’s extensive knowledge of numerous business sectors will add an important dimension and a unique perspective to the Johnson & Johnson Board of Directors. I am incredibly proud of the background, diversity, and caliber of all our Board members and on behalf of the Board, we look forward to working with Darius as the Company continues to deliver transformational innovation, create healthier communities, and put better health within reach of more people around the world”, stated Alex Gorsky, Executive Chairman, Johnson & Johnson.
Darius Adamczyk stated, “I am honored to join Johnson & Johnson’s Board of Directors at this important time for both the Company and for the future of healthcare. Johnson & Johnson is a values-driven organization that is helping people lead better lives and creating healthier communities. I look forward to working with my fellow directors in support of the management team as they continue to create long-term value for all of Johnson & Johnson’s stakeholders.”
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare-focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
